Benchmark Downgrades Immunoprecise Antibodies Ltd. (IPA) to Speculative Buy

March 21, 2023 11:54 AM EDT Send to a Friend
Benchmark analyst Robert Wasserman downgraded Immunoprecise Antibodies Ltd. (NASDAQ: IPA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login